Fredun Pharmaceuticals Delivers Stellar Q1 FY27 Performance; Revenue Jumps 90%, EBITDA Surges 93% and Profit Rises 95% YoY
Mumbai (Maharashtra) [India], August 6: Fredun Pharmaceuticals Limited (BSE: FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Q1 FY27 Standalone Financial Highlights Total Income of ₹228.25 Cr, YoY […]
Continue Reading